Owens & Minor (NYSE:OMI) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Owens & Minor (NYSE:OMI – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Saturday.

OMI has been the topic of several other research reports. Credit Suisse Group dropped their price objective on Owens & Minor from $20.00 to $17.00 and set a neutral rating on the stock in a report on Tuesday, March 7th. Citigroup dropped their price objective on Owens & Minor from $20.00 to $17.00 and set a neutral rating on the stock in a report on Wednesday, March 8th. Finally, Robert W. Baird dropped their price objective on Owens & Minor from $23.00 to $18.00 and set a neutral rating on the stock in a report on Wednesday, March 1st. Two analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Hold and a consensus price target of $17.20.

Owens & Minor Stock Down 1.6 %

NYSE:OMI traded down $0.20 during trading hours on Friday, hitting $12.66. The company’s stock had a trading volume of 3,316,440 shares, compared to its average volume of 1,425,402. The stock has a market capitalization of $965.70 million, a P/E ratio of 45.22, a price-to-earnings-growth ratio of 8.97 and a beta of 0.60. The stock has a fifty day moving average of $18.81 and a 200-day moving average of $20.37. The company has a current ratio of 1.47, a quick ratio of 0.61 and a debt-to-equity ratio of 2.63. Owens & Minor has a 52-week low of $12.47 and a 52-week high of $47.24.

Owens & Minor (NYSE:OMI – Get Rating) last issued its quarterly earnings data on Tuesday, February 28th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.11). The firm had revenue of $2.55 billion for the quarter, compared to analysts’ expectations of $2.46 billion. Owens & Minor had a return on equity of 19.29% and a net margin of 0.22%. The business’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.81 EPS. On average, equities analysts forecast that Owens & Minor will post 1.18 earnings per share for the current year.

Institutional Investors Weigh In On Owens & Minor

Hedge funds have recently made changes to their positions in the business. Ronald Blue Trust Inc. boosted its stake in shares of Owens & Minor by 307.1% during the third quarter. Ronald Blue Trust Inc. now owns 1,026 shares of the company’s stock worth $33,000 after buying an additional 774 shares during the period. Hallmark Capital Management Inc. acquired a new stake in Owens & Minor in the third quarter valued at about $25,000. Lazard Asset Management LLC acquired a new stake in Owens & Minor in the third quarter valued at about $25,000. US Bancorp DE lifted its position in Owens & Minor by 67.4% in the first quarter. US Bancorp DE now owns 1,145 shares of the company’s stock valued at $51,000 after purchasing an additional 461 shares during the period. Finally, Alpha Paradigm Partners LLC acquired a new stake in Owens & Minor in the second quarter valued at about $49,000.

About Owens & Minor

(Get Rating)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations.